254 related articles for article (PubMed ID: 17151963)
1. Heparin-protamine does not aggravate local LPS-provoked leukocytic inflammation in vivo.
Schramm R; Nickels RM; Harder Y; Langer F; Menger MD; Schäfers HJ
Thorac Cardiovasc Surg; 2006 Dec; 54(8):506-11. PubMed ID: 17151963
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the leukocyte-endothelial cell interaction in collecting venules of skeletal muscle by protamine.
Habazettl H; Martinek V; Vollmar B; Conzen P
J Thorac Cardiovasc Surg; 1997 Apr; 113(4):784-91. PubMed ID: 9104989
[TBL] [Abstract][Full Text] [Related]
3. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE
Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
[TBL] [Abstract][Full Text] [Related]
4. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
5. Strategies for improving the functionality of an affinity bioreactor.
Wang T; Yang Z; Emregul E; David A; Balthasar JP; Liang J; Yang VC
Int J Pharm; 2005 Dec; 306(1-2):132-41. PubMed ID: 16246511
[TBL] [Abstract][Full Text] [Related]
6. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
[TBL] [Abstract][Full Text] [Related]
7. Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier.
Nickel JC; Downey J; Morales A; Emerson L; Clark J
J Urol; 1998 Aug; 160(2):612-4. PubMed ID: 9679938
[TBL] [Abstract][Full Text] [Related]
8. Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist.
Cushing DJ; Cooper WD; Cohen ML; McVoy JR; Sobel M; Harris RB
Eur J Pharmacol; 2010 Jun; 635(1-3):165-70. PubMed ID: 20307530
[TBL] [Abstract][Full Text] [Related]
9. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
[TBL] [Abstract][Full Text] [Related]
10. Effects of inhaled nanoparticles on acute lung injury induced by lipopolysaccharide in mice.
Inoue K; Takano H; Yanagisawa R; Hirano S; Kobayashi T; Fujitani Y; Shimada A; Yoshikawa T
Toxicology; 2007 Sep; 238(2-3):99-110. PubMed ID: 17614186
[TBL] [Abstract][Full Text] [Related]
11. Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele.
Shastri KA; Logue GL; Stern MP; Rehman S; Raza S
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):482-8. PubMed ID: 9305203
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effects of low-dose radiotherapy in an experimental model of systemic inflammation in mice.
Arenas M; Gil F; Gironella M; Hernández V; Jorcano S; Biete A; Piqué JM; Panés J
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):560-7. PubMed ID: 16965998
[TBL] [Abstract][Full Text] [Related]
13. Gravity sedimentation of leukocytes is partially independent from erythrocyte sedimentation.
Bogar LL; Tarsoly PP
Clin Hemorheol Microcirc; 2006; 34(3):439-45. PubMed ID: 16614468
[TBL] [Abstract][Full Text] [Related]
14. Role of heparin and nitric oxide in the cardiac and regional hemodynamic properties of protamine in conscious chronically instrumented dogs.
Oguchi T; Doursout MF; Kashimoto S; Liang YY; Hartley CJ; Chelly JE
Anesthesiology; 2001 Jun; 94(6):1016-25. PubMed ID: 11465593
[TBL] [Abstract][Full Text] [Related]
15. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
[TBL] [Abstract][Full Text] [Related]
16. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
Chang LC; Lee HF; Chung MJ; Yang VC
Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans.
Dehmer GJ; Lange RA; Tate DA; Pirwitz M; Daniel W; Fisher M; Bonnem EM
Circulation; 1996 Nov; 94(9 Suppl):II347-52. PubMed ID: 8901773
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review.
Boer C; Meesters MI; Veerhoek D; Vonk ABA
Br J Anaesth; 2018 May; 120(5):914-927. PubMed ID: 29661409
[TBL] [Abstract][Full Text] [Related]
19. The peptide analogue of MCP-1 65-76 sequence is an inhibitor of inflammation.
Chazov EI; Bespalova JD; Arefieva TI; Kukhtina NB; Sidorova MV; Provatorov SI; Krasnikova TL
Can J Physiol Pharmacol; 2007; 85(3-4):332-40. PubMed ID: 17612642
[TBL] [Abstract][Full Text] [Related]
20. Radiation and primary response to lipopolysaccharide: bone marrow-derived cells and susceptible organs.
Gridley DS; Miller GM; Pecaut MJ
In Vivo; 2007; 21(3):453-61. PubMed ID: 17591354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
